Filter Results:
(7,887)
Show Results For
- All HBS Web
(7,887)
- People (21)
- News (2,650)
- Research (4,135)
- Events (21)
- Multimedia (297)
- Faculty Publications (3,375)
Show Results For
- All HBS Web
(7,887)
- People (21)
- News (2,650)
- Research (4,135)
- Events (21)
- Multimedia (297)
- Faculty Publications (3,375)
- 10 Dec 2001
- Conference Presentation
Psychological Sequelae of Early Trauma II: Comorbid Diagnoses or Diagnostic Entity?
By: Margaret E. Blaustein, Joseph Spinazzola, William B. Simpson and Bessel van der Kolk
- 27 Apr 2023
- News
Life Preserver
because they lack access to an organ transplant. Worldwide, the World Health Organization estimates only 10 percent of the need for organ transplantation is being met. And the gap between the demand and supply is even greater in some... View Details
Keywords: April White
- 28 Aug 2019
- Working Paper Summaries
Who Drives Digital Innovation? Evidence from the US Medical Device Industry
- January 2021
- Case
Aster DM Healthcare: Budgeting for a Crisis
By: V.G. Narayanan and Amy Klopfenstein
In April 2020, Alisha Moopen, Deputy Managing Director of Aster DM Healthcare, a network of clinics, hospitals, and pharmacies in the Middle East and India, must create her company’s budget for the 2021 fiscal year in light of the onset of Covid-19. The pandemic had... View Details
Keywords: Decision Making; Decisions; Forecasting and Prediction; Judgments; Decision Choices and Conditions; Cost vs Benefits; Budgets and Budgeting; Health Pandemics; Health Industry; Asia; India; United Arab Emirates; Dubai
Narayanan, V.G., and Amy Klopfenstein. "Aster DM Healthcare: Budgeting for a Crisis." Harvard Business School Case 121-001, January 2021.
- 07 Jan 2022
- News
Learning to Fight
Mark Johnson, one of the early recipients of the foundation’s signature Distinguished Scientist Award. Johnson is now chair of the Department of Neurological Surgery at UMass Memorial Health and a professor at the University of... View Details
- December 2021
- Article
Primary Care Access During the COVID-19 Pandemic: a Simulated Patient Study
By: Michael Anne Kyle, Renuka Tipirneni, Nitya Thakore, Sneha Dave and Ishani Ganguli
Background
Primary care practices have experienced major strains during the COVID-19 pandemic, such that patients newly seeking care may face potential barriers to timely visits.
Objective
To quantify availability and wait times for new patient... View Details
Primary care practices have experienced major strains during the COVID-19 pandemic, such that patients newly seeking care may face potential barriers to timely visits.
Objective
To quantify availability and wait times for new patient... View Details
Keywords: COVID-19; Ambulatory Care; Policy/economics; Access; Telemedicine; Health Pandemics; Health Care and Treatment
Kyle, Michael Anne, Renuka Tipirneni, Nitya Thakore, Sneha Dave, and Ishani Ganguli. "Primary Care Access During the COVID-19 Pandemic: a Simulated Patient Study." Journal of General Internal Medicine 36, no. 12 (December 2021): 3766–3771.
- Article
Patterns of Failure after Involved Field Radiation Therapy for Pediatric and Young Adult Hodgkin Lymphoma
By: Minh-Phuong Huynh-Le, Amanda J. Walker, Scott Duke Kominers, Ido Paz-Priel, Moody D. Wharam and Stephanie A. Terezakis
Involved field radiation therapy (IFRT) is integral in curative therapy for Hodgkin lymphoma (HL), although primarily used in patients with intermediate/high‐risk HL. We present failure patterns and clinical outcomes in a cohort of pediatric and young adult patients... View Details
Keywords: Hematology/oncology; Hodgkin Lymphoma; Involved Field Radiation Therapy; Health Disorders; Health Care and Treatment
Huynh-Le, Minh-Phuong, Amanda J. Walker, Scott Duke Kominers, Ido Paz-Priel, Moody D. Wharam, and Stephanie A. Terezakis. "Patterns of Failure after Involved Field Radiation Therapy for Pediatric and Young Adult Hodgkin Lymphoma." Pediatric Blood & Cancer 61, no. 7 (July 2014).
- 18 Feb 2016
- News
Challenge Aims to Speed Drug Trials Process
The HBS Health Care Initiative is seeking innovative ideas from the science, patient, business, and medical communities on how to transform trials for precision medicine. Through the HBS Precision Trials Challenge, it aims to bring... View Details
- 24 Sep 2020
- News
The Race for a Vaccine
country, manufacturing capacity, supply chains, and money, lots of money. As the head of the United Kingdom’s new Vaccine Taskforce, Kate Bingham (MBA 1991) has a bird's-eye view of the whole process. A life science venture capitalist with SV View Details
- April 2011 (Revised March 2012)
- Supplement
U.S. Healthcare Reform: Reaction to the Patient Protection and Affordable Care Act of 2010
By: Arthur A. Daemmrich
Supplement to "U.S. Healthcare Reform: International Perspectives" updating key events and disputes concerning the reform law, including the 2010 Congressional elections, legislative proposals, legal challenges, and responses by employers. View Details
Keywords: Governing Rules, Regulations, and Reforms; Government Legislation; Political Elections; Health Care and Treatment; Lawsuits and Litigation; Business and Government Relations; Public Opinion; Health Industry; Health Industry; United States
Daemmrich, Arthur A. "U.S. Healthcare Reform: Reaction to the Patient Protection and Affordable Care Act of 2010." Harvard Business School Supplement 711-103, April 2011. (Revised March 2012.)
- 01 Jun 2017
- News
Starting Lineup: Values Proposition
by publicly traded health care IT company Allscripts. Rumi Spice Cofounder and CEO Kimberly Jung (MBA 2015); Founded 2014 With the goal of spurring development in rural Afghanistan, Rumi works with 80-plus farmers and hundreds of saffron... View Details
- 11 Aug 2014
- HBS Case
The Business of Behavioral Economics
of these principles with individuals, can they be used by companies to help employees meet their health and other goals? Norton has been experimenting with one behavioral economic principle—social norming—in order to test incentives for... View Details
- December 2002
- Teaching Note
Abgenix and the XenoMouse (TN)
Teaching Note for (501-061). View Details
- July 2017 (Revised July 2019)
- Supplement
"Doctor My Eyes"--The Acquisition of Bausch & Lomb by Warburg Pincus (B)
By: Nori Gerardo Lietz and Ricardo Andrade
The B Case of "Dr. My Eyes" provides the answer as to what happened after the ending fact pattern in Case A and the imminent choices faced by the protagonist in the primary case. At the end of the Case A, Bess Weatherman of Warburg Pincus, must chose one option of two... View Details
Keywords: Private Equity; Health Care and Treatment; Mergers and Acquisitions; Corporate Governance; Decision Choices and Conditions; Outcome or Result; Health Industry; Health Industry; Health Industry
Lietz, Nori Gerardo, and Ricardo Andrade. "Doctor My Eyes"--The Acquisition of Bausch & Lomb by Warburg Pincus (B). Harvard Business School Supplement 218-029, July 2017. (Revised July 2019.)
- October 2004 (Revised July 2005)
- Case
Kinetic Concepts, Inc.
By: Jay W. Lorsch, Dwight B. Crane and Ashley Robertson
Raises issues about how the nature and function of a board changes as a company moves from ownership by its employees, including the founder, to ownership by a private equity firm, Fremont Partners, culminating in a highly successful IPO. Gives students the opportunity... View Details
Keywords: Private Equity; Governing and Advisory Boards; Initial Public Offering; Behavior; Organizations; Employee Ownership; Health Care and Treatment; Health Industry; Health Industry; United States
Lorsch, Jay W., Dwight B. Crane, and Ashley Robertson. "Kinetic Concepts, Inc." Harvard Business School Case 405-042, October 2004. (Revised July 2005.)
- 8 Aug 1990 - 12 Aug 1990
- Conference Presentation
Multidimensional Scaling of DSM-III Personality Disorders in Two Populations
By: W. B. Simpson, M. J. Lyons, L. Young and M. T. Tsuang
- September 2006 (Revised April 2007)
- Case
Medtronic Vision 2010
Describes the company's year-long efforts to transition from a medical device company selling products to physicians for use with patients suffering chronic end-stage disease, to a medical technology company providing life-long solutions for people with chronic... View Details
Keywords: Business Plan; Transition; Decision Choices and Conditions; Corporate Entrepreneurship; Financial Management; Financing and Loans; Health Care and Treatment; Innovation and Invention; Strategic Planning; Health Industry
Applegate, Lynda M. "Medtronic Vision 2010." Harvard Business School Case 807-051, September 2006. (Revised April 2007.)
- 01 Dec 2013
- News
Your Own Medicine
level of creatine kinase—an enzyme indicative of muscle damage—in a normal person's blood is around 50 units per liter, maybe as high as 100 after a workout. Charley's was 20,000. It suggested muscular dystrophy. Related Links Curing View Details